These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4560226)

  • 21. [Recommendations for immunosuppressive therapy of childhood glomerular kidney diseases].
    Bläker F
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):252. PubMed ID: 5055849
    [No Abstract]   [Full Text] [Related]  

  • 22. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E
    Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of nephrotic syndrome of children with immunosuppressive agents (literature survey)].
    Sergeeva KM; Grinbaum NB
    Vopr Okhr Materin Det; 1975 Nov; 20(11):46-9. PubMed ID: 1220157
    [No Abstract]   [Full Text] [Related]  

  • 24. Corticosteroid and immunosuppressive treatment in glomerulonephritis. (Literature review).
    Alatas H
    Paediatr Indones; 1974; 14(7-8):135-42. PubMed ID: 4617177
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term assessment of cyclophosphamide therapy for nephrosis in children.
    McDonald J; Murphy AV; Arneil GC
    Lancet; 1974 Oct; 2(7887):980-2. PubMed ID: 4138088
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunosuppressive therapy of nephrotic syndrome].
    Yamashita F
    Nihon Shonika Gakkai Zasshi; 1971; 75(9):813-5. PubMed ID: 5165877
    [No Abstract]   [Full Text] [Related]  

  • 27. [Immunosuppressive therapy in familial nephrotic syndrome].
    Turay P; Horváth E; Korill F; Szabó S
    Kinderarztl Prax; 1975 Apr; 43(4):145-50. PubMed ID: 1223367
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences with cytotoxic drugs in therapy of the nephrotic syndrome].
    Brandis M; Krohn HP; Hanke K; Brodehl J
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):566-8. PubMed ID: 876240
    [No Abstract]   [Full Text] [Related]  

  • 29. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis].
    Lagrue G; Bariety J
    Minerva Med; 1970 Jul; 61(55):3054-63. PubMed ID: 5427678
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunosuppressive treatment of nephrotic syndrome.
    Orlowski T; Wojtulewicz-Kurkus J; Glyda J; Kunert Z
    Pol Med J; 1969; 8(3):552-71. PubMed ID: 4186260
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
    Chen SY; Wu CY; Tsai IJ; Tsau YK
    Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children.
    Grupe WE; Heymann W
    Am J Dis Child; 1966 Nov; 112(5):448-58. PubMed ID: 5917978
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytostatic treatment of nephrotic syndrome in children.
    Miltényi M; Marosvári I; Román H; Visy M; Beregi E; Szepesházi K
    Acta Paediatr Acad Sci Hung; 1970; 11(3):263-76. PubMed ID: 5525401
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapy for the child with nephrotic syndrome.
    Rose GM
    Compr Ther; 1982 Oct; 8(10):14-9. PubMed ID: 7140199
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lupus erythematosus, modern aspects (author's transl)].
    Canavese JC
    Schweiz Rundsch Med Prax; 1977 May; 66(19):565-72. PubMed ID: 69300
    [No Abstract]   [Full Text] [Related]  

  • 36. The familial nephrotic syndrome. I. A European survey.
    White RH
    Clin Nephrol; 1973; 1(4):215-9. PubMed ID: 4783718
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of immunosuppressive treatment of nephrotic syndrome].
    Przybyl L; Salwa-Kubasik W; Urbański K; Wróz M; Hryniewiecki J
    Pol Tyg Lek; 1973 Jun; 28(26):990-3. PubMed ID: 4727614
    [No Abstract]   [Full Text] [Related]  

  • 38. Corticosteroid and immunosuppressive therapy of idiopathic nephrotic syndrome.
    Lindeman RD
    J Okla State Med Assoc; 1971 Nov; 64(11):448-54. PubMed ID: 5120014
    [No Abstract]   [Full Text] [Related]  

  • 39. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R; Brem AS
    Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Incidence in the past decade of nephrotic syndrome in childhood Therapeutic result of the use of 3 corticosteroids].
    Bosco Borghesan A; Cutaja I; Maringhini S
    Minerva Pediatr; 1980 Aug; 32(15):939-42. PubMed ID: 7464745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.